BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 234 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.37 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $17,415 | +534.9% | 2,818 | +421.9% | 0.00% | – |
| Q1 2024 | $2,743 | -33.0% | 540 | -21.1% | 0.00% | – |
| Q4 2023 | $4,097 | +74.9% | 684 | +106.6% | 0.00% | – |
| Q3 2023 | $2,343 | -67.3% | 331 | -67.5% | 0.00% | -100.0% |
| Q2 2023 | $7,160 | +224.0% | 1,017 | +283.8% | 0.00% | – |
| Q1 2023 | $2,210 | -10.9% | 265 | +22.7% | 0.00% | – |
| Q4 2022 | $2,480 | +24.0% | 216 | +54.3% | 0.00% | – |
| Q3 2022 | $2,000 | 0.0% | 140 | -35.8% | 0.00% | – |
| Q2 2022 | $2,000 | -50.0% | 218 | -3.5% | 0.00% | -100.0% |
| Q1 2022 | $4,000 | – | 226 | -8.9% | 0.00% | – |
| Q1 2020 | $0 | – | 248 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 3,846,154 | $40,692,000 | 16.07% |
| Fairmount Funds Management LLC | 3,343,107 | $35,370,000 | 8.10% |
| Kynam Capital Management, LP | 936,563 | $9,909,000 | 2.53% |
| Velan Capital Investment Management LP | 225,000 | $2,381,000 | 2.42% |
| ORACLE INVESTMENT MANAGEMENT INC | 603,994 | $6,390,000 | 1.94% |
| TANG CAPITAL MANAGEMENT LLC | 1,200,000 | $12,696,000 | 1.93% |
| MPM BioImpact LLC | 639,089 | $6,762,000 | 1.88% |
| Ghost Tree Capital, LLC | 325,000 | $3,439,000 | 1.79% |
| Sarissa Capital Management LP | 1,390,790 | $14,715,000 | 1.48% |
| Prosight Management, LP | 176,680 | $1,869,000 | 1.47% |